EUVIMEDSkopri EUVIMED
Netzwerk-MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC 4.0

The Optimal Dose, Efficacy and Safety of Tranexamic Acid on Hemorrhage Control for High Tibial Osteotomy: A Network Meta‐Analysis

Zhihu Zhao, Fei Xing, Wei Luo, Xin-Long Ma iD

Orthopaedic Surgery · 2025

DOI: 10.1111/os.70140 ↗

At a glance

Netzwerk-Metaanalyse in Orthopaedic Surgery, 2025. Written by Zhihu Zhao and 3 co-authors. Institution: Department of Orthopaedics, Tianjin Hospital, Tianjin, China. Major MEDLINE topics: Antifibrinolytic Agents, Blood Loss, Surgical, Osteotomy, Postoperative Hemorrhage. Cited 2 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation of China, Tianjin Health Research Project, Tianjin Municipal Science and Technology Bureau Project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

This systematic review and network meta‐analysis was performed to explore the optimal dose, efficacy, and safety of tranexamic acid ( TXA ) treatments versus placebo for high tibial osteotomy ( HTO ) patients.

Methods

PubMed , Embase, Cochrane Library, Wanfang database, and Chinese National Knowledge Infrastructure ( CNKI ) databases were searched for the randomized controlled trials ( RCTs ) meeting prespecified inclusion criteria up to March 2024. Interventions included TXA and placebo treatments. The outcomes included total blood loss, drainage, hemoglobin drop, the occurrence of deep venous thrombosis ( DVT ) and hematoma. Traditional meta‐analysis and network meta‐analysis were performed by Stata and R software, respectively.

Results

Traditional meta‐analysis revealed that TXA was associated with a decrease in the total blood loss, drainage volume, and hemoglobin drop ( p < 0.05). There was no significant difference between TXA and placebo in terms of the occurrence of DVT and hematoma ( p > 0.05). Compared with placebo, intravenous (iv) 10 mg/kg, iv 10 mg/kg (3 doses), iv 2 g, iv 2 g (2 doses), iv 2 g + topical (top) 3 g, iv 50 mg/kg, and top 10 mg/kg decreased the total blood loss with statistical significance ( p < 0.05). Compared with placebo, iv 10 mg/kg ( WMD = −379.91, 95% CI: −378.92, −81.22) decreased the drainage volume with statistical significance. Compared with placebo, iv 10 mg/kg (3 doses), iv 1 g, iv 1 g + top 2 g, iv 2 g + top 1 g, and iv 50 mg/kg decreased the hemoglobin drop with statistical significance. No statistically significant difference was found when the two interventions were compared against each other for the occurrence of DVT and hematoma ( p > 0.05). The SUCRA shows that iv 10 mg/kg ranked first for reducing total blood loss ( SUCRA , 90.7%) and drainage volume ( SUCRA , 94.3%). The SUCRA shows that iv 1 g + top 2 g ranked first ( SUCRA , 93.7%) for reducing hemoglobin drop.

Conclusion

Administration with TXA was associated with a decrease in blood loss in HTO patients. The optimal dose of TXA for reducing blood loss was iv 10 mg/kg. As for reducing hemoglobin drop, iv 1 g + top 2 g ranked first. Administration of TXA was not associated with an increase in the occurrence of DVT and hematoma. However, most evidence was graded as low/very low confidence due to study limitations, imprecision, and heterogeneity. Therefore, these findings should be interpreted as preliminary signals rather than definitive conclusions. Further high‐quality randomized trials are required to validate dose‐dependent efficacy and long‐term safety outcomes.

Subjects

MeSH terms (MEDLINE)

Antifibrinolytic AgentsBlood Loss, SurgicalOsteotomyPostoperative HemorrhageTibiaTranexamic AcidHumansDose-Response Relationship, DrugRandomized Controlled Trials as Topic

Author keywords

blood lossdeep venous thrombosishematomahigh tibial osteotomynetwork meta‐analysistranexamic acid

Substances

Antifibrinolytic AgentsTranexamic Acid

Authors and institutions

  • Department of Orthopaedics, Tianjin Hospital, Tianjin, China.

ORCID profiles: Xin-Long Ma

Funding

  • National Natural Science Foundation of China
  • Tianjin Health Research Project
  • Tianjin Municipal Science and Technology Bureau Project
  • Tianjin Qingnian Yixue Xinrui

Cite

APA

Zhao, Z., Xing, F., Luo, W., & Ma, X. L. (2025). The Optimal Dose, Efficacy and Safety of Tranexamic Acid on Hemorrhage Control for High Tibial Osteotomy: A Network Meta‐Analysis. Orthopaedic Surgery. https://doi.org/10.1111/os.70140

Vancouver

Zhao Z, Xing F, Luo W, Ma XL. The Optimal Dose, Efficacy and Safety of Tranexamic Acid on Hemorrhage Control for High Tibial Osteotomy: A Network Meta‐Analysis. Orthopaedic Surgery. 2025. doi:10.1111/os.70140

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhihu and Xing, Fei and Luo, Wei and Ma, Xin-Long},
  title = {The Optimal Dose, Efficacy and Safety of Tranexamic Acid on Hemorrhage Control for High Tibial Osteotomy: A Network Meta‐Analysis},
  journal = {Orthopaedic Surgery},
  year = {2025},
  doi = {10.1111/os.70140}
}
Start for free →